Description - Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 1, 2006 by Jeffrey L. Cummings
Published annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists.
Buy Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 1, 2006 by Jeffrey L. Cummings from Australia's Online Independent Bookstore, Boomerang Books.
(247mm x 174mm x 13mm)
Cambridge University Press
Publisher: Cambridge University Press
Country of Publication:
Other Editions - Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 1, 2006 by Jeffrey L. Cummings
Book Reviews - Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 1, 2006 by Jeffrey L. Cummings
Author Biography - Jeffrey L. Cummings
Jeffrey L. Cummings, MD, is currently Director of both the Deane F. Johnson Center for Neurotherapeutics at UCLA, and the UCLA Alzheimer's Disease Center. He holds the Augustus Rose Professor of Neurology chair, was the Shrinavasan Lecturer in 2004 and the Henderson Lecturer in 2005.